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In the version of this article initially published, Figures 2 and 3 were incorrectly reproduced in the publishing process. The publisher wishes to apologize for any inconvenience caused.

On the pages 432 and 434, figures should be corrected as following.

From

![Cumulative incidence rates of liver-related event (LRE) development. The cumulative incidence rates of LRE development at 1, 2, and 3 years were 0.5%, 1.1%, and 2.1%, respectively.\
AFP, α-fetoprotein.](gnl-10-653f1){#f1-gnl-10-653}

To

![Cumulative incidence rates of liver-related event (LRE) development. The cumulative incidence rates of LRE development at 1, 2, and 3 years were 0.5%, 1.1%, and 2.1%, respectively.](gnl-10-653f2){#f2-gnl-10-653}

From

![Cumulative incidence rates of liver-related event (LRE) development based on stratified age and liver stiffness values. The cumulative incidence rates of LRE development increased significantly in older patients (A), those with higher α-fetoprotein (AFP) levels (B), and those with higher liver stiffness (LS) values at sustained virological response (C) (log-rank test, all p\<0.05).](gnl-10-653f3){#f3-gnl-10-653}

To

![Cumulative incidence rates of liver-related event (LRE) development based on stratified age and liver stiffness values. The cumulative incidence rates of LRE development increased significantly in older patients (A), those with higher α-fetoprotein (AFP) levels (B), and those with higher liver stiffness (LS) values at sustained virological response (C) (log-rank test, all p\<0.05).](gnl-10-653f4){#f4-gnl-10-653}
